Dr. Floyd G Pohle, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 104 N Beech St, Woodville, TX 75979 Phone: 409-283-2822 Fax: 409-283-7852 |
News Archive
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has initiated a Phase 2/3 clinical trial of its proprietary investigational drug ADS-5102 (amantadine HCl extended release) for the treatment of levodopa induced dyskinesia (LID) in patients with Parkinson's disease.
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced that it received a patent for a laparoscopic electrosurgical electrical leakage detection device.
Researchers at the University of Colorado Health Sciences Center have announced the findings of a large-scale clinical trial for patients with late-stage heart failure. Results showed that cardiac resynchronization therapy (CRT) from implantable pacemaker-like devices or CRT combined with an implantable defibrillator (CRT-D), when used in addition to optimal drug therapy, reduced significantly the mortality and first hospitalization rate when compared to drug therapy alone. CRT-D also substantially lowered mortality.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
› Verified 1 days ago